Pharmaceutical development relies heavily on the availability of high-quality chemical intermediates, and 4-Methyldiphenylamine (CAS 620-84-8) is a notable example. This organic compound serves as a critical building block in the synthesis of various active pharmaceutical ingredients (APIs) and other vital drug components. For professionals in the pharmaceutical industry, understanding its properties and how to procure it efficiently is key to accelerating research and production timelines.

4-Methyldiphenylamine, identified by its molecular formula C13H13N, is typically supplied with a high purity of 99.0% or more. This stringent purity level is essential for pharmaceutical synthesis, where even trace impurities can impact the efficacy and safety of the final drug product. When you need to buy this intermediate, partnering with a manufacturer that adheres to strict quality control measures is paramount. Such suppliers often provide detailed Certificates of Analysis (CoA) to verify purity and composition.

The versatility of 4-methyldiphenylamine as a pharmaceutical intermediate stems from its chemical structure, which allows it to participate in a variety of organic reactions. It can be incorporated into complex molecular structures to create new therapeutic agents. R&D scientists often search for this compound when exploring synthetic routes for novel drug candidates. For those involved in early-stage drug discovery or process development, obtaining samples and quotes for 4-methyldiphenylamine is a common practice.

Beyond its direct role in API synthesis, 4-methyldiphenylamine may also be used in the production of related pharmaceutical chemicals or as a reagent in specific analytical procedures within drug development. The ability to reliably purchase this intermediate in required quantities, from grams for research to metric tons for commercial production, is a critical factor for pharmaceutical companies. Working with an established supplier in China can offer a strategic advantage in terms of cost-effectiveness and supply chain robustness.

For procurement managers and chemists in the pharmaceutical sector, identifying a consistent and trustworthy source for 4-methyldiphenylamine is a priority. Factors such as lead times, packaging options, and adherence to regulatory standards should be evaluated. If your project requires this key intermediate, reaching out to experienced chemical providers for detailed information and pricing is an essential step toward successful acquisition.